Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :14706656
Publication Date : //

The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.


Lafora's disease (LD) is an autosomal recessive and fatal form of epilepsy with onset in late childhood or adolescence. One of the characteristic features of LD pathology is the presence of periodic acid-Schiff (PAS) positive Lafora inclusion bodies. Lafora bodies are present primarily in neurons, but they have also been found in other organs. Histochemical and biochemical studies have indicated that Lafora bodies are composed mainly of polysaccharides. The LD gene, EPM2A, encodes a 331 amino acid long protein named laforin that contains an N-terminal carbohydrate-binding domain (CBD) and a C-terminal dual-specificity phosphatase domain (DSPD). Here we demonstrate that the CBD of laforin targets the protein to Lafora inclusion bodies and this property could be evolutionarily conserved. We also tested in vitro the effects of five LD missense mutations on laforin's affinity to Lafora body. While the missense mutant W32G failed to bind to purified Lafora body, four other mutants (S25P, E28L, F88L, and R108C) did not show any effect on the binding affinity. Based on these observations we propose the existence of a laforin-mediated glycogen metabolic pathway regulating the disposal of pathogenic polyglucosan inclusions. This is the first report demonstrating a direct association between the LD gene product and the disease-defining storage product, the Lafora bodies.

Authors : Ganesh Subramaniam , Tsurutani Naomi , Suzuki Toshimitsu , Hoshii Yoshinobu , Ishihara Tokuhiro , Delgado-Escueta Antonio V , Yamakawa Kazuhiro ,

Related products :

Catalog number Product name Quantity
20-372-60229 epilepsy. progressive myoclonus type 2A. Lafora disease (laforin) (EPM2A). transcript variant 1 - Mouse monoclonal anti-human EPM2A antibody; EC 3.1.3.48; EC 3.1.3.16; Lafora PTPase; LAFPTPase Monoclo 0.1 mg
EPN1 EPM2A Gene epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
60229 IgG,epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A), transcript variant 1 0.1 mg
GWB-835A73 epilepsy progressive myoclonus type 2A Lafora disease (laforin) (EPM2A) transcript variant 1, Antibody
CSB-EL007738RA Rat epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Rat, Sample Type serum, plasma 96T
CSB-EL007738DO Dog epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Dog, Sample Type serum, plasma 96T
CSB-EL007738MO Mouse epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
CSB-EL007738HU Human epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Human, Sample Type serum, plasma 96T
EIAAB13124 Epm2a,Lafora PTPase,Laforin,LAFPTPase,Mouse,Mus musculus
EIAAB13122 Epm2a,Lafora PTPase,Laforin,LAFPTPase,Rat,Rattus norvegicus
EIAAB13123 EPM2A,Homo sapiens,Human,Lafora PTPase,Laforin,LAFPTPase
orb82331 C. trachomatis D Elem. Bodies protein Chlamydia trachomatis D (UW-3_Cx Strain) Elementary Bodies is an infectious disease antigen_toxin. For research use only. 1 ml
EIAAB13121 Canis familiaris,Canis lupus familiaris,Dog,EPM2A,Lafora PTPase,Laforin,LAFPTPase
27-508 RNF12 is a RING-H2 zinc finger protein. It has been shown to be a ubiquitin protein ligase that targets LIM domain binding 1 (LDB1_CLIM), and causes proteasome-dependent degradation of LDB1. This prot 0.05 mg
EIAAB27462 CARD15,Caspase recruitment domain-containing protein 15,Homo sapiens,Human,IBD1,Inflammatory bowel disease protein 1,NOD2,Nucleotide-binding oligomerization domain-containing protein 2
31-278 ETS2 contains an ETS DNA-binding domain and belongs to the ETS family. ETS2 is a target of protein kinase C and upregulates GM-CSF. Ets2 and its targets play essential roles in endothelial cell functi 0.05 mg
31-170 ETS2 contains an ETS DNA-binding domain and belongs to the ETS family. ETS2 is a target of protein kinase C and upregulates GM-CSF. Ets2 and its targets play essential roles in endothelial cell functi 0.05 mg
30-904 COIL is an integral component of Cajal bodies (also called coiled bodies). Cajal bodies are nuclear suborganelles of varying number and composition that are involved in the post-transcriptional modifi 0.05 mg
U0497h CLIA 35 kDa lectin,Carbohydrate-binding protein 35,CBP 35,Gal-3,Galactose-specific lectin 3,Galactoside-binding protein,GALBP,Galectin-3,Homo sapiens,Human,IgE-binding protein,L-31,Laminin-binding pro 96T
E0497h ELISA 35 kDa lectin,Carbohydrate-binding protein 35,CBP 35,Gal-3,Galactose-specific lectin 3,Galactoside-binding protein,GALBP,Galectin-3,Homo sapiens,Human,IgE-binding protein,L-31,Laminin-binding pr 96T
29-424 PUM2 is a sequence-specific RNA-binding protein that regulates translation and mRNA stability by binding the 3'-UTR of mRNA targets. Its interactions and tissue specificity suggest that it may be requ 0.1 mg
18-003-44039 LIM domain-binding protein 1 - Nuclear LIM interactor; Carboxyl-terminal LIM domain-binding protein 2; CLIM-2; LIM domain-binding factor CLIM2; hLdb1 Polyclonal 0.05 mg Aff Pur
18-003-42854 LIM domain-binding protein 2 - Carboxyl-terminal LIM domain-binding protein 1; CLIM-1; LIM domain-binding factor CLIM1 Polyclonal 0.1 mg Protein A
18-003-43098 LIM domain-binding protein 2 - Carboxyl-terminal LIM domain-binding protein 1; CLIM-1; LIM domain-binding factor CLIM1 Polyclonal 0.1 mg Protein A
E0497h ELISA kit 35 kDa lectin,Carbohydrate-binding protein 35,CBP 35,Gal-3,Galactose-specific lectin 3,Galactoside-binding protein,GALBP,Galectin-3,Homo sapiens,Human,IgE-binding protein,L-31,Laminin-bindi 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur